MARKET

HQH

HQH

abrdn Healthcare Investors
NYSE
18.62
+0.05
+0.27%
Opening 12:49 07/22 EDT
OPEN
18.58
PREV CLOSE
18.57
HIGH
18.81
LOW
18.57
VOLUME
65.18K
TURNOVER
0
52 WEEK HIGH
18.97
52 WEEK LOW
13.92
TOTAL ASSET
1.06B
YTD YIELD
12.69%
1D
5D
1M
3M
1Y
5Y
1D
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
Abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. The fund's managed distribution policy was increased significantly since our prior update. The abrdn healthcare investors fund continues to trade at an attractive discount. Discount Narrows With Distribution Increase But Remains Appealing.
Seeking Alpha · 4d ago
HQH: Double-Digit Discount And Dividend Ready For Biotech Rally
Abrdn Healthcare Investors (HQH) features a deep NAV discount at 11%. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good buy for income investors to participate in the promising biotech rally. Record financing activities in the sector fuel the business growth and set up biotech for a rally in 2024.
Seeking Alpha · 5d ago
Weekly Report: what happened at HQH last week (0708-0712)?
Weekly Report · 07/15 09:01
Make Money While You Sleep, 2 Big Dividends For A Retirement Dream
Home Dividends Analysis Dividend Ideas Make Money While You Sleep, 2 Big Dividents For A Retirement Dream. Rida Morwa Investing Group Leader looks at two funds to help you fund your retirement. OXLC - Yield 19.3% is currently in the "sweet spot" with low default rates.
Seeking Alpha · 07/13 11:35
Weekly Report: what happened at HQH last week (0701-0705)?
Weekly Report · 07/08 09:01
BME: Quality Healthcare Fund With 6% Income And An Attractive Discount
Seeking Alpha · 07/07 13:00
Weekly Report: what happened at HQH last week (0624-0628)?
Weekly Report · 07/01 09:01
Weekly Report: what happened at HQH last week (0617-0621)?
Weekly Report · 06/24 09:01
More
Profile
Fund Name
abrdn Healthcare Investors
Inception Date
1987-04-23
Benchmark
NASDAQ Biotechnology TR USD
Advisor Company
Tekla Capital Management LLC
Custodian
State Street Bank and Trust Co
Manager
Jason Akus, Daniel Omstead